Related Experiment Videos
[Arterial thrombolysis. Review and future prospects]
1Service de Chirurgie thoracique et vasculaire, Hôpital Marie-Lannelongue, Le Plessis-Robinson.
Journal Des Maladies Vasculaires
|January 1, 1988
Summary
This review compares classical and modern thrombolytic agents for arterial fibrinolysis, discussing their efficacy, administration, and future applications in treating arterial obstructions and acute limb ischemia.
Area of Science:
- Cardiovascular medicine
- Pharmacology
Context:
- Thrombolytic therapy is crucial for managing arterial obstructions.
- Classical agents like streptokinase and urokinase have known complications.
- Modern agents offer improved efficacy and targeted delivery.
Purpose:
- To review the mechanism of action, results, and complications of thrombolytic agents.
- To discuss future perspectives in arterial fibrinolysis.
- To compare the efficacy of different thrombolytic agents and administration methods.
Summary:
- Classical (streptokinase, urokinase) and modern (acyl enzyme, tPA, scuPA) thrombolytic agents are analyzed for arterial fibrinolysis.
- Comparative efficacy in peripheral and coronary pathology is discussed.
- Optimal administration methods for enhanced local concentration and reduced systemic effects are explored.
Impact:
- Informs clinical decision-making for arterial fibrinolysis.
- Guides the development of more effective and safer thrombolytic strategies.
- Aims to optimize treatment for acute limb ischemia and other arterial pathologies.